Tag Archives: BTK inhibitor

COVID-19: AstraZeneca to start clinical trial to assess Calquence potential in reducing mortality and need for assisted ventilation in patients

The trial, called CALAVI, will assess the effect of Calquence on the exaggerated immune response of patients hospitalised with COVID-19 infection (PRESS RELEASE) CAMBRIDGE, 14-Apr-2020 — /EuropaWire/ — Pharmaceutical giant AstraZeneca to begin a randomised, global clinical trial to assess … Read the full press release